Exact sciences

Another groundbreaking study on regulated cell death

— Editors
share on twitter share on facebook share on linkedin send by email print

A multidisciplinary team of scientists, including Dr. hab. Karolina Mikulska-Ruminska, from the Department of Biophysics at the Institute of Physics at the Nicolaus Copernicus University, made another important discovery related to the process of ferroptosis by identifying two new inhibitors that block the process of ferroptosis.

 The findings were published in the prestigious journal Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Ferroptosis is a form of regulated cell death, different from better known apoptosis or necrosis. Ferroptosis characteristic feature is increasing level of lipid peroxides. Therefore, free radicals take electrons from the lipids causing the cell damage. Ferroptosis was identified as the mechanism of cell death in Parkinson and Huntington's diseases, and sepsis. It plays a critical role in the treatment of cancers, and may contribute to the degradation of tissue in brain trauma, kidney diseases and asthma. Although, a lot of interest of that process can be seen among scientists, the explanation still remains unclear.

The above mentioned team of scientists designed, synthesized and tested a group of compounds using biochemical, molecular and cell biology models, as well as lipidomic studies and computer modeling. This led to the discovery of two compounds that were able to effectively inhibit ferroptosis without affecting the biosynthesis of pro/anti-inflammatory lipid mediators used by the immune system.

The study on this topic was reported in the recent article "The discovery of selective antiferroptotic inhibitors, another groundbreaking study on regulated cell death" in the Proceedings of the National Academy of Sciences of the United States of America (2023).The studies were i.a. supported by the National Science Centre (Poland) and National Institutes of Health (NIH).

Dr hab. Karolina Mikulska-Rumińska graduated from bachelor's and masters' degree studies in medical physics in the faculty of Physics, Astronomy and Informatics of Nicolaus Copernicus University in Toruń.  In 2014, she defended with honors her doctoral dissertation.

During her doctoral studies, she took part in two internships: in a pharmaceutical company ADAMED, and as a beneficiary of European Grant Sciex-NMSch – in Laboratory of Physics of Living Matter at École Polytechnique Fédérale de Lausanne (EPFL) in Switzerland. At the same time, she was awarded a grant PRELUDIUM3 financed by National Center of Science (NCN) and she was employed as an assistant in the Faculty of Physics, Astronomy and Informatics, NCU.

In 2016, she began a 2,5-year post-doctoral internship in School of Medicine in Pittsburgh, USA under the supervision of prof. Ivet Bahar, where, i.a. she participated in the projects of National Institute of Health (NIH). After returning to Poland, she was promoted to the position of adjunct and received a grant of National Center of Science SONATA15.

She is an author of more than 30 publications.  The recent years, she has devoted to intensive research on the process of ferroptosis.

 

Rules od sharing information
share on twitter share on facebook share on linkedin send by email print

Related articles

Rising talent of the world’s science

Article contains a clip

Award for New Physics


Strength of results consistency and agreement

Mysterious source of fast radio bursts

Article contains a clip

On Nicolaus Copernicus University web pages „cookies” are used. On use of cookies read in Privacy policy.
Cookies settings
On Nicolaus Copernicus Pages "cookies" are used in accord with our Privacy policy. We use "cookies" to improve functionality of our web page. Collected data are anonymized and are used to statistic and analytic purposes, for better adjusting content to user preferences and increase of quality. To approach this goal we use Google Analytics, CUX i Facebook Pixel to. Below we give you the ability of turning on/off this tools.
  on/off
Google Analitics

We use analytic tool Google Analytics, which give us information about user visits on our service (visited pages, navigation path, time of visit)

CUX

We use analytic tool CUX to regisiter visits on NCU News.

Facebook Pixel

We use marketing tool Facebook Pixel, to collect information about user visits and viewed pages.